Stahl, S. M. (2003). "The ups and downs of novel antiemetic drugs, part 2: an illustration." J Clin Psychiatry 64(6): 626-627.

	Novel antiemetic drugs block either neurokinin-1 receptors or serotonin-3 receptors. Research into the neuropharmacology of vomiting is providing insight into the ways substance P and serotonin interact within the central nervous system that could lead to additional applications of neurokinin-1 antagonists for the treatment of depression and stress.

